VIE Equity Snapshot

BIIB Weekly Equity Report

Biogen Inc.

Interactive chart JSON snapshot
Latest Close 174.4 EUR 12 Jun 2026
1W Return 0.9% latest completed week
4W Return 5.4% short-term follow-through
12W Return 10.5% quarterly tape
Trend Breadth 71.2% 37 of 52 weeks active
Volume Ratio 0.2x vs 13-week average
Company Brief

What the company does

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE. It offers LEQEMBI for the treatment of Alzheimer's disease; ZURZUVAE for the treatment of postpartum depression; RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid …

Snapshot

What the weekly tape is saying

BIIB closed the latest completed week at 174.4 EUR. The 4-week return is 5.4% and the 12-week return is 10.5%. Trend Signal is active, Market Dynamics is 0.34. Setup signature: Balanced read with a 67/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 10.5%
Volume 0.2x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 84 Persistence of active Trend Signal over the last year and current streak.
Momentum 72 Blend of 4-week and 12-week follow-through.
Dynamics 100 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 51 Relative leadership and short-term RS change.
Volume 6 Participation compared with the 13-week volume baseline.
Risk Control 87 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
157.8 EUR
Vs Trend Line
10.5%
Fair Value
172.6 EUR
Vs Fair Value
1.0%
52W High
175.8 EUR
52W Low
103.7 EUR
Drawdown
-0.8%
Range Position
98.0%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.9%
4W 5.4%
12W 10.5%
26W 17.6%
52W 53.2%

Trend read

Active Streak
37 weeks
52W Active Weeks
37
52W Active Breadth
71.2%
Sector Scope
AT Healthcare
Sector Rank
31 of 112
Sector Percentile
73.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.34
4W MD Change
950.7%
Relative Strength
1.63
4W RS Change
-54.3%
Expectation
Undecided
Probability
53.06%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
9
13W Average
59
52W Average
40
Vs 13W
0.2x
Vs 52W
0.2x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
2.7%
52W Volatility
4.5%
Upside Weeks
32
Downside Weeks
20
Downside Breadth
38.5%
Avg Gain / Loss
3.6% / -3.3%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
VIE
Country
AT
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
EUR
Market Cap
24.8B

Opportunity signals

  • Trend Signal is active with a 37-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • No major top-level risk cluster is currently dominant.

Watch next

  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 174.4 EUR 0.9% 157.8 EUR 172.6 EUR 0.34 1.63 9 On
5 Jun 2026 172.9 EUR 2.4% 156.9 EUR 173.3 EUR 0.17 3.77 38 On
29 May 2026 168.9 EUR 2.0% 155.5 EUR 174.0 EUR -0.01 0.44 10 On
22 May 2026 165.6 EUR 0.1% 154.3 EUR 174.7 EUR 0.04 1.35 48 On
15 May 2026 165.5 EUR 0.7% 153.1 EUR 175.4 EUR 0.03 3.57 139 On
8 May 2026 164.3 EUR 0.7% 151.7 EUR 176.2 EUR -0.31 2.64 0 On
1 May 2026 163.1 EUR 3.9% 150.4 EUR 176.9 EUR -0.57 3.72 245 On
24 Apr 2026 156.9 EUR 4.6% 149.5 EUR 177.7 EUR -0.77 0.64 56 On
17 Apr 2026 150.1 EUR 1.3% 148.2 EUR 178.5 EUR -0.61 -6.93 0 On
10 Apr 2026 148.2 EUR -4.2% 147.3 EUR 179.2 EUR -0.31 -5.90 0 On
3 Apr 2026 154.6 EUR -4.8% 146.5 EUR 179.9 EUR -0.04 4.52 67 On
27 Mar 2026 162.4 EUR 2.9% 145.4 EUR 180.6 EUR 0.08 13.47 105 On
20 Mar 2026 157.9 EUR -1.9% 143.8 EUR 181.2 EUR -0.07 11.91 45 On
13 Mar 2026 160.9 EUR 2.4% 142.5 EUR 181.8 EUR -0.08 12.54 8 On